BALFX
Price
$36.48
Change
+$0.09 (+0.25%)
Updated
Jun 27 closing price
Net Assets
250.05B
PGPRX
Price
$26.50
Change
+$0.05 (+0.19%)
Updated
Jun 27 closing price
Net Assets
2.18B
Interact to see
Advertisement

BALFX vs PGPRX

Header iconBALFX vs PGPRX Comparison
Open Charts BALFX vs PGPRXBanner chart's image
American Funds American Balanced F1
Price$36.48
Change+$0.09 (+0.25%)
VolumeN/A
Net Assets250.05B
George Putnam Balanced R
Price$26.50
Change+$0.05 (+0.19%)
VolumeN/A
Net Assets2.18B
BALFX vs PGPRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALFX vs. PGPRX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a Buy and PGPRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 250B vs. PGPRX (2.18B). BALFX pays higher dividends than PGPRX: BALFX (1.88) vs PGPRX (1.42). BALFX was incepted earlier than PGPRX: BALFX (24 years) vs PGPRX (22 years). PGPRX (1.18) is less costly to investors than BALFX (0.61). PGPRX is a more actively managed with annual turnover of: 80.00 vs. BALFX (44.00). PGPRX has a lower initial minimum investment than BALFX: PGPRX (0) vs BALFX (250). BALFX annual gain was more profitable for investors over the last year : 7.55 vs. PGPRX (6.61). BALFX return over 5 years is better than : 42.93 vs. PGPRX (35.50).
BALFXPGPRXBALFX / PGPRX
Total Expense Ratio0.611.1852%
Annual Report Gross Expense Ratio0.611.1852%
Fund Existence24 years22 years-
Gain YTD6.9904.397159%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets250B2.18B11,457%
Annual Yield % from dividends1.881.42133%
Returns for 1 year7.556.61114%
Returns for 3 years34.0039.2087%
Returns for 5 years42.9335.50121%
Returns for 10 years63.8271.5889%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DFH25.290.80
+3.27%
Dream Finders Homes
IT402.76-1.84
-0.45%
Gartner
NTLA9.56-0.05
-0.52%
Intellia Therapeutics
LSTA2.80-0.14
-4.76%
Lisata Therapeutics
AKYA1.24-0.09
-6.77%
Akoya BioSciences